More than one million people in the United States today are fighting blood cancer. While a traditional
allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotechnology company redefining the transplant process by developing next-generation cell therapies with the goal of providing significantly better survival rates with dramatically fewer risks.
With our purified, high-precision investigational cell therapies we hope to not only replace patients' blood and immune systems with healthy ones, but also restore their lives. Summary:
Reporting to the Head of CMC, you will play a pivotal role in supporting the development, qualification, transfer and validation of analytical methods focused on the potency assays for our cell-based products, which are purified from mobilized peripheral blood and are composed of hematopoietic stem and progenitor cells (HSPCs), regulatory T cells (Treg) and conventional T cells (Tcons).
Building on existing assays, you will work to finalize and generate the potency strategy with a matrix of technologies that characterize the biological products being developed in clinical trials. In addition, you will coordinate the transfer and validation of potency assays to our Quality Control (QC) team for late-stage development and commercialization. The ideal candidate will possess a strong scientific background, attention to detail, and adaptability to evolving priorities. Previous experience in the development of assays for cell based biological products is advantageous.
Success Milestones:
Success will be marked by significant contributions to the preparation of Biological License Application (BLA) and commercial readiness for our biological products. Over a short period of time, you will gain invaluable expertise in late-stage process development.
The anticipated annual salary range for this job is $100,000– $175,000, based on prior experience in the role/industry, education, location, internal equity, and other job-related factors as permitted by law. For remote-based candidates, this range may vary based on your local market. You will also be eligible to receive pre-IPO equity, in addition to medical, dental, and vision benefits, flexible PTO, 401(k) plan, life and accidental death and disability coverage, and parental leave benefits. Other perks include free daily lunches and snacks at our on-site locations.
Who we are
We are driven by a passion for science and compassion for patients. We act with urgency to ensure our treatments are one day accessible to all who need them.
We live by our core values of passion, courage, and integrity. Excellence in our work means the chance to unlock a better quality of life for our patients, and with that comes tremendous responsibility.
We innovate on a path that hasn’t been paved. We embrace an entrepreneurial spirit and take calculated risks to achieve our mission. We aren’t afraid to ask “why not” and challenge the status quo.
We maintain a start-up culture of camaraderie and leadership by example, regardless of title.
We’re proud to be an equal opportunity employer, and recognize that celebrating our differences creates stronger, lasting solutions that better serve our team, our patients and their healthcare providers.
Notice to staffing firms
Orca Bio does not accept resumes from staffing agencies with which we do not have a written agreement and specific engagement for a particular opening. Our employment activities, inquiries and offers are managed through our HR/Talent team, and all candidates are presented through this channel only. We do not accept unsolicited resumes, and we rarely outsource recruitment.